Authors: BYSTRYN JC ORATZ R SHAPIRO R HARRIS M ROSES D JACQUOTTE A

Citation: Jc. Bystryn et al., RANDOMIZED, DOUBLE-BLIND, CLINICAL-TRIAL OF A POLYVALENT MELANOMA VACCINE IN PATIENTS WITH STAGE-III MELANOMA, Journal of investigative dermatology, 110(4), 1998, pp. 498-498

Authors: BYSTRYN JC REYNOLDS SR ORATZ R SHAPIRO RL HARRIS M ROSES D

Citation: Jc. Bystryn et al., STIMULATION OF CD8-CELL RESPONSES TO MAGE-3 AND MART-1 BY IMMUNIZATION TO A SHED ANTIGEN MELANOMA VACCINE( T), Journal of investigative dermatology, 108(4), 1997, pp. 113-113

Authors: MOEZZI M MELAMED J VAMVAKAS E INGHIRAMI G MITNICK J QUISH A BOSE S ZELMAN G ROSES D HARRIS M FEINER H

Citation: M. Moezzi et al., MORPHOLOGICAL AND BIOLOGICAL CHARACTERISTICS OF MAMMOGRAM-DETECTED INVASIVE BREAST-CANCER, Human pathology, 27(9), 1996, pp. 944-948

Authors: BYSTRYN JC ORATZ R SHAPIRO R JOHNSTON D HARRIS M ROSES D ZELENIUCHJACQUOTTE A CHEN DL LAX A

Citation: Jc. Bystryn et al., POTENTIATION OF MELANOMA VACCINE ACTIVITY BY IL-2 LIPOSOMES, Journal of investigative dermatology, 106(4), 1996, pp. 235-235